Shuren Ma

Title: Shuren Ma: Innovator in COPD Treatment

Introduction

Shuren Ma is a notable inventor based in Cliffside Park, NJ (US), recognized for his contributions to medical innovations, particularly in the treatment of chronic obstructive pulmonary disease (COPD). With a total of two patents to his name, Ma has made significant strides in developing methods for diagnosing and treating elastin fiber injuries.

Latest Patents

Shuren Ma's latest patents focus on cell culture models for validating candidate compounds intended for use in treating COPD and other related diseases. The inventions detail methods for diagnosing, monitoring, and treating elastin fiber injuries. They emphasize the importance of validating candidate compounds by measuring the degradation of elastic fibers in patients. By utilizing mass spectrometry with an internal standard, these methods assess markers of elastic fiber degradation in body fluids or tissues. A decrease in the presence of these markers compared to a control validates the effectiveness of the candidate compounds in treating, preventing, or ameliorating diseases such as COPD, chronic bronchitis, emphysema, and refractory asthma.

Career Highlights

Throughout his career, Shuren Ma has worked with esteemed institutions such as St. Luke's-Roosevelt Hospital Center and Columbia University. His work in these organizations has contributed to advancements in medical research and treatment methodologies.

Collaborations

Shuren Ma has collaborated with notable colleagues, including Gerard M. Turino and Yong Y. Lin, enhancing the impact of his research through shared expertise and knowledge.

Conclusion

Shuren Ma's innovative work in the field of COPD treatment showcases his dedication to improving patient outcomes through scientific research and invention. His contributions continue to influence the medical community and pave the way for future advancements in healthcare.